Answering Your Questions about Parkinson’s disease and Coronavirus Disease 2019 (COVID-19) Posted on March 26, 2020March 26, 2020 by Dr. Rebecca Gilbert Answering Your Questions about Parkinson’s disease and Coronavirus Disease 2019 (COVID-19) – Updated With the continued spread of Coronavirus Disease 2019, also known as COVID-19, in the United States and throughout the world, Parkinson’s disease (PD) patients have been reaching out and asking questions and we’re here with the answers you need. As such, we […] Read More
The 26th Annual Parkinson’s Unity Walk Posted on January 13, 2020January 13, 2020 by Phil Franchina The American Parkinson Disease Association (APDA) is a proud partner of the 26th Annual Parkinson’s Unity Walk taking place on Saturday, April 25, 2020 in Central Park, New York City. 100% of donations raised by the event will go to research funded by the leading PD foundations, including APDA. In addition to raising awareness and funds […] Read More
The FDA approves F-Dopa PET imaging to aid in early diagnosis of Parkinson’s disease Posted on January 8, 2020January 8, 2020 by Dr. Rebecca Gilbert The FDA approves F-Dopa PET imaging to aid in early diagnosis of Parkinson’s disease The FDA recently approved Flourodopa F18 (F-Dopa), a radioactive tracer for positron emission tomography (PET) that can help visualize the nerve endings of dopaminergic neurons. It can be used to help in the diagnosis of Parkinson’s disease (PD) and other parkinsonian […] Read More
Promising results from the University of Pittsburgh APDA Center for Advanced Research Posted on October 24, 2019December 12, 2019 by Phil Franchina Promising results from the University of Pittsburgh APDA Center for Advanced Research Building off of pivotal APDA-funded work highlighted here, Dr. J. Timothy Greenamyre and his team, published a new study investigating the role of Leucine-rich Repeat Kinase (LRRK2) in the development of Parkinson’s disease (PD). LRRK2 is known to be mutated in a small […] Read More
Taking Parkinson’s education to the farmers market: educating under-served communities Posted on September 16, 2019September 16, 2019 by Phil Franchina Taking Parkinson’s education to the farmers market: educating under-served communities Dr. Lynda Nwabuobi, Movement Disorder Fellow at Columbia Presbyterian Medical Center in New York City, attended APDA’s Diversity in Parkinson’s Disease (PD) Research Conference in May and was inspired. Dr. Nwabuobi had just spent the day learning about health care disparities in PD care, low […] Read More
APDA ANNOUNCES $1.7 MILLION IN NEW PARKINSON’S DISEASE RESEARCH GRANTS. FUNDING ENABLES 10 RESEARCHERS TO CONDUCT IMPACTFUL RESEARCH. Posted on September 10, 2019February 25, 2020 by Dr. Rebecca Gilbert APDA announces funding for 2019-2020 grants It is that time of year – when APDA announces our research grantees for the 2019-2020 fiscal year. We are very proud of our grant recipients who each has a unique idea that will hopefully benefit the entire Parkinson’s disease (PD) community. This year APDA has awarded $1.7 million […] Read More
New medication, Istradefylline, gets approved for Parkinson’s disease Posted on September 4, 2019 by Stephanie Paul New medication, Istradefylline, gets approved for Parkinson’s disease On August 27, 2019, pharmaceutical company Kyowa Kirin received FDA approval for Istradefylline, a new medication for Parkinson’s disease (PD) to be used as an add-on treatment to carbidopa/levodopa for those experiencing OFF episodes. (For more information on OFF periods in PD, please see this recent APDA […] Read More
APDA Seed Funding Leads to Prestigious NIH Research Grant Posted on August 16, 2019August 16, 2019 by Stephanie Paul APDA Seed Funding Leads to Prestigious NIH Research Grant APDA is exceptionally proud to congratulate Dr. Beom-Chan Lee, APDA Research Grant awardee on receiving a recently-awarded National Institutes of Health (NIH) R21 grant. Read More
APDA-funded research finds new role for alpha-synuclein Posted on July 30, 2019July 31, 2019 by Stephanie Paul APDA-funded research finds new role for alpha-synuclein This new understanding of alpha-synuclein’s function could open up new ways of thinking about treatments for Parkinson’s disease. Read More
Fighting Parkinson’s Disease Around the World – Highlights from the World Parkinson Congress Posted on June 25, 2019November 19, 2019 by Guest Author Fighting Parkinson’s Disease Around the World – Highlights from the World Parkinson Congress APDA was in Kyoto for the 5th WPC — an international forum for dialogue on the latest scientific discoveries, medical practices, and caregiver initiatives. Read More
